Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for Alcohol Use Disorder
NCT03732248Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in alcohol use disorder (AUD) comparing Rapamycin with Placebo (2 arms). Primary endpoint: Monitoring of Side-Effects Scale at Day 10. Started Jul 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03732248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03732248.